Literature DB >> 27730484

Herpes Zoster Vaccine: Time for a Boost?

Krishna P Reddy1.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 27730484      PMCID： PMC5264680          DOI： 10.1007/s11606-016-3885-x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  10 in total

1.  Long-term persistence of zoster vaccine efficacy.

Authors:  Vicki A Morrison; Gary R Johnson; Kenneth E Schmader; Myron J Levin; Jane H Zhang; David J Looney; Robert Betts; Larry Gelb; John C Guatelli; Ruth Harbecke; Connie Pachucki; Susan Keay; Barbara Menzies; Marie R Griffin; Carol A Kauffman; Adriana Marques; John Toney; Kathy Boardman; Shu-Chih Su; Xiaoming Li; Ivan S F Chan; Janie Parrino; Paula Annunziato; Michael N Oxman
Journal:  Clin Infect Dis       Date:  2014-11-20       Impact factor: 9.079

2.  Declining Effectiveness of Herpes Zoster Vaccine in Adults Aged ≥60 Years.

Authors:  Hung Fu Tseng; Rafael Harpaz; Yi Luo; Craig M Hales; Lina S Sy; Sara Y Tartof; Stephanie Bialek; Rulin C Hechter; Steven J Jacobsen
Journal:  J Infect Dis       Date:  2016-02-09       Impact factor: 5.226

3.  Determining the Optimal Vaccination Schedule for Herpes Zoster: a Cost-Effectiveness Analysis.

Authors:  Phuc Le; Michael B Rothberg
Journal:  J Gen Intern Med       Date:  2016-10-14       Impact factor: 5.128

4.  A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

Authors:  M N Oxman; M J Levin; G R Johnson; K E Schmader; S E Straus; L D Gelb; R D Arbeit; M S Simberkoff; A A Gershon; L E Davis; A Weinberg; K D Boardman; H M Williams; J Hongyuan Zhang; P N Peduzzi; C E Beisel; V A Morrison; J C Guatelli; P A Brooks; C A Kauffman; C T Pachucki; K M Neuzil; R F Betts; P F Wright; M R Griffin; P Brunell; N E Soto; A R Marques; S K Keay; R P Goodman; D J Cotton; J W Gnann; J Loutit; M Holodniy; W A Keitel; G E Crawford; S-S Yeh; Z Lobo; J F Toney; R N Greenberg; P M Keller; R Harbecke; A R Hayward; M R Irwin; T C Kyriakides; C Y Chan; I S F Chan; W W B Wang; P W Annunziato; J L Silber
Journal:  N Engl J Med       Date:  2005-06-02       Impact factor: 91.245

5.  The cost-effectiveness of preventing AIDS-related opportunistic infections.

Authors:  K A Freedberg; J A Scharfstein; G R Seage; E Losina; M C Weinstein; D E Craven; A D Paltiel
Journal:  JAMA       Date:  1998-01-14       Impact factor: 56.272

6.  Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older.

Authors:  Anthony L Cunningham; Himal Lal; Martina Kovac; Roman Chlibek; Shinn-Jang Hwang; Javier Díez-Domingo; Olivier Godeaux; Myron J Levin; Janet E McElhaney; Joan Puig-Barberà; Carline Vanden Abeele; Timo Vesikari; Daisuke Watanabe; Toufik Zahaf; Anitta Ahonen; Eugene Athan; Jose F Barba-Gomez; Laura Campora; Ferdinandus de Looze; H Jackson Downey; Wayne Ghesquiere; Iris Gorfinkel; Tiina Korhonen; Edward Leung; Shelly A McNeil; Lidia Oostvogels; Lars Rombo; Jan Smetana; Lily Weckx; Wilfred Yeo; Thomas C Heineman
Journal:  N Engl J Med       Date:  2016-09-15       Impact factor: 91.245

7.  Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Rafael Harpaz; Ismael R Ortega-Sanchez; Jane F Seward
Journal:  MMWR Recomm Rep       Date:  2008-06-06

8.  Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

Authors:  Michael B Rothberg; Anunta Virapongse; Kenneth J Smith
Journal:  Clin Infect Dis       Date:  2007-04-03       Impact factor: 9.079

9.  Cellular and Humoral Responses to a Second Dose of Herpes Zoster Vaccine Administered 10 Years After the First Dose Among Older Adults.

Authors:  Myron J Levin; Kenneth E Schmader; Lei Pang; Angela Williams-Diaz; Gary Zerbe; Jennifer Canniff; Michael J Johnson; Yupanqui Caldas; Alice Cho; Nancy Lang; Shu-Chih Su; Janie Parrino; Zoran Popmihajlov; Adriana Weinberg
Journal:  J Infect Dis       Date:  2015-10-09       Impact factor: 5.226

10.  Update on recommendations for use of herpes zoster vaccine.

Authors:  Craig M Hales; Rafael Harpaz; Ismael Ortega-Sanchez; Stephanie R Bialek
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-08-22       Impact factor: 17.586
  10 in total
  2 in total

Review 1.  Varicella and herpes zoster vaccine development: lessons learned.

Authors:  Charlotte Warren-Gash; Harriet Forbes; Judith Breuer
Journal:  Expert Rev Vaccines       Date:  2017-10-30       Impact factor: 5.217

2.  Varicella zoster virus vaccines: an update.

Authors:  Giovanni Gabutti; Niccolò Bolognesi; Federica Sandri; Caterina Florescu; Armando Stefanati
Journal:  Immunotargets Ther       Date:  2019-08-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.